Universal Health Services (NYSE:UHS) is a prominent player in the healthcare sector, providing hospital and healthcare services across the United States. The company operates a network of acute care hospitals, behavioral health facilities, and ambulatory centers. UHS competes with other healthcare giants like HCA Healthcare and Tenet Healthcare, striving to deliver quality care and maintain financial growth.
On October 28, 2025, Barclays set a new price target of $263 for UHS, a significant increase from its current stock price of $214.03. This target suggests a potential 22.88% rise, reflecting confidence in UHS's future performance. The stock's recent price movement, with a 1.59% increase to $214.03, indicates positive investor sentiment.
UHS's strong financial results for the quarter ending September 2025 support Barclays' optimistic outlook. The company reported a revenue of $4.5 billion, a 13.4% increase from the previous year, surpassing the Zacks Consensus Estimate of $4.31 billion. This resulted in a positive surprise of 4.23%, showcasing UHS's ability to exceed market expectations.
The company's earnings per share (EPS) also impressed, reaching $5.69 compared to $3.71 in the same quarter last year. This EPS exceeded the consensus estimate of $4.66, delivering a substantial surprise of 22.1%. Such strong financial performance highlights UHS's capability to drive growth and profitability, reinforcing the positive outlook on its stock price.
UHS's market capitalization stands at approximately $13.62 billion, reflecting its significant presence in the healthcare industry. The stock's trading volume today is 921,195 shares, indicating active investor interest. With a 52-week high of $214.28 and a low of $152.33, UHS's stock performance demonstrates resilience and potential for further growth.
